Picture of Cryosite logo

CTE Cryosite Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapHigh Flyer

Annual cashflow statement for Cryosite, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2018
June 30th
2019
June 30th
C2020
June 30th
C2021
June 30th
2022
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital0.0070.0061.010.050
Other Operating Cash Flow
Cash from Operating Activities-0.262-0.6481.320.5152.52
Capital Expenditures-0.181-0.026-0.91-0.397-0.863
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items0.0420.0580.0280.0230.003
Other Investing Cash Flow
Cash from Investing Activities-0.1390.032-0.882-0.374-0.86
Financing Cash Flow Items0-0.038-0.035-0.005
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities00-0.292-0.295-0.181
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.401-0.6160.142-0.1811.46

Or unlock with your email

Or unlock with your email